Biopharma PEG , a leading PEG linker supplier, offers PEGylation as a cost-effective modification of peptides which has the potential to improve bioavailability compared to the nmodified molecule
Patients on additional anticoagulant or antiplatelet therapy, such as aspirin
While the efficacy of levocarnitine injection to increase carnitine concentrations in patients with ESRD undergoing dialysis has been demonstrated, the effects of supplemental carnitine on the signs and symptoms of carnitine deficiency and on clinical outcomes in this population have not been determined
For Research Use Only Not intended for human consumption or therapeutic use
Based on comparable medications, monthly costs likely range from $1,000-1,400 CAD
Attaining a high encapsulation efficiency is essential for a successful drug delivery